Perezida Kagame na Madamu Bakingiwe COVID-19

Perezida Paul Kagame na Jeannette Kagame bakingiwe icyorezo cya COVID-19 nyuma y’iminsi itandatu igikorwa cyo gukingira iyi ndwara gitangijwe mu gihugu hose, haherewe ku bafite ibyago byinshi byo kwandura cyangwa kuzahazwa n’icyo cyorezo.

Bakingiriwe mu Bitaro Byitiriwe Umwami Faisal mu Mujyi wa Kigali kuri uyu wa Kane.

Ibikorwa by’ikingira byatangiye ku wa 5 Werurwe ubwo u Rwanda rwari rumaze kwakira inkingo zikabakaba 347.000 za COVID-19 zo mu bwoko bwa AstraZeneca/Oxford na Pfizer/BioNTech zabonetse muri gahunda mpuzamahanga igamije gufasha ibihugu kubona inkingo, COVAX.

Zaje kwiyongeraho inkingo 50.000 u Rwanda rwahawe n’u Buhinde.

- Advertisement -

Kugeza kuri uyu wa Gatatu hari hamaze gukingirwa abaturarwanda 228.954.

Mu bakingiwe ku ikubitiro harimo abaganga n’intsinda rishinzwe gukurikiranira hafi, kurwanya no gukumira icyorezo cya COVID-19 mu Rwanda, abarimu, abajyanama b’ubuzima, imfungwa n’abagororwa ndetse n’abafite imyaka 65 kuzamura.

Harimo n’abandi batoranyijwe mu byiciro by’abarwaye indwara zidakira, abamugaye, abakozi bo ku kibuga cy’indege, abacuruzi n’abatwara taxi.

Mu bakingiwe kandi harimo abamotari n’abanyonzi n’impunzi haherewe ku nkambi y’agateganyo ya Gashora, icumbikiye impunzi zavanywe muri Libya.

Abahawe urukingo bose bazongera guhabwa urwa kabiri nyuma y’ibyumweru bine kugira ngo urukingo rube rwuzuye neza. Abakingiwe bose bibutswa ko guhabwa urukingo bidakuraho andi mabwiriza yose yo kwirinda ikwirakwira rya COVID-19.

Leta y’u Rwanda yihaye umuhigo wo gukingira 30% by’abaturarwanda bose mbere y’uko umwaka wa 2021 urangira na 60% mbere y’uko uwa 2022 urangira. Hazaba hakingiwe abantu nibura miliyoni 7.8.

Leta y’u Rwanda ivuga ko ikomeje ibiganiro n’ibindi bihugu, abakora inkingo ndetse n’abafatanyabikorwa batandukanye kugira ngo haboneke inkingo zihagije.

Ubwo Jeannette Kagame yaterwaga urukingo rwa COVID-19
Perezida Kagame yatewe urukingo ku kuboko bw’ibumoso
Perezida Kagame na Madamu bakingiriwe mu Bitaro Byitiriwe Umwami Faisal
Share This Article
1 Comment

Leave a Reply to Karegeya Cancel reply

Your email address will not be published. Required fields are marked *

Exit mobile version